MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test sale cost 4400 AED
WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test sale cost 4400 AED WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
TPRN Gene Deafness Autosomal Recessive Type 79 Genetic Test sale cost 4400 AED TPRN Gene Deafness Autosomal Recessive Type 79 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MYO3A gene that are linked to a form of hereditary hearing loss. This condition, known as Autosomal Recessive Deafness Type 30 (DFNB30), is characterized by the inheritance of two defective copies of the MYO3A gene, one from each parent, leading to early-onset hearing impairment. The test is crucial for families with a history of this condition, as it provides vital information for making informed decisions about management and intervention strategies.

Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations associated with DFNB30. The process is highly accurate and can pinpoint the genetic alterations responsible for the condition, offering insights into the likelihood of passing the mutation to future generations. Given the autosomal recessive inheritance pattern, understanding one’s carrier status is particularly important for family planning purposes.

DNA Labs UAE, known for its state-of-the-art genetic testing services, ensures confidentiality and provides comprehensive support throughout the testing process. The results from this test not only aid in confirming a diagnosis but also play a critical role in guiding audiologists and other healthcare professionals in tailoring the most appropriate intervention and support for individuals affected by this form of genetic hearing loss.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test

At DNA Labs UAE, we offer the MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test to help diagnose and provide important information for genetic counseling, prognosis, and potential treatment options. Here are the details of the test:

Test Components

  • Test Name: MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Before undergoing the MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test, it is important to provide the clinical history of the patient who is going for the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A genetic counseling session will also be conducted to draw a pedigree chart of family members affected with the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS9.

Test Details

The MYO3A gene is responsible for producing a protein called myosin IIIA, which is crucial for the normal functioning of sensory hair cells in the inner ear. Deafness, autosomal recessive type 30 (DFNB30) is a genetic condition characterized by hearing loss present from birth. This condition is caused by mutations in the MYO3A gene, which disrupt the production or function of the myosin IIIA protein. As a result, sensory hair cells in the inner ear are impaired, leading to hearing loss.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes or even the entire genome simultaneously. In the case of MYO3A gene deafness, an NGS genetic test involves sequencing the MYO3A gene to identify any mutations or variations. This test helps confirm a diagnosis of DFNB30 and provides important information for genetic counseling, prognosis, and potential treatment options.

Additionally, NGS genetic testing can be used for carrier testing to determine if an individual carries a mutation in the MYO3A gene. This information is crucial for family planning purposes.

By offering the MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test, DNA Labs UAE aims to provide accurate diagnoses and valuable information for individuals and families affected by DFNB30. Our test is conducted using NGS technology and is performed by our expert team in the Genetics department. The test results are delivered within 3 to 4 weeks.

For more information about the MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test or to schedule an appointment, please contact our ENT Doctor.

Test Name MYO3A Gene Deafness autosomal recessive type 30 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS9
Test Details

The MYO3A gene is responsible for providing instructions for the production of a protein called myosin IIIA. This protein is found in the inner ear and plays a crucial role in the normal functioning of sensory hair cells, which are responsible for converting sound vibrations into electrical signals that can be interpreted by the brain.

Deafness, autosomal recessive type 30 (DFNB30) is a genetic condition characterized by hearing loss that is present from birth. It is caused by mutations in the MYO3A gene, which disrupt the normal production or function of the myosin IIIA protein. This leads to the impairment of sensory hair cells in the inner ear, resulting in hearing loss.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of MYO3A gene deafness, an NGS genetic test would involve sequencing the MYO3A gene to identify any mutations or variations that may be present.

By identifying specific mutations in the MYO3A gene, NGS genetic testing can help confirm a diagnosis of DFNB30 and provide important information for genetic counseling, prognosis, and potential treatment options. It can also be used for carrier testing to determine if an individual carries a mutation in the MYO3A gene, which can be important for family planning purposes.

SKU: TEST-2716 Category:

Related products